Smokers with MS have greater decrements in quality of life and disability than non-smokers.

ABSTRACT:

Background

Tobacco smoke plays a pathogenic role in multiple sclerosis (MS) and may accelerate disease progression, yet, some people with MS continue to smoke after disease onset. The average smoker reports diminished health-related quality of life (HRQOL) across many populations.

Objectives

To describe the relationships between smoking status and HRQOL, disease activity, and global disability in a US population with MS.

Methods

We compared smokers to non-smokers in 950 responders to the Spring 2014 update survey completed by North American Research Committee on Multiple Sclerosis (NARCOMS) registry participants. HRQOL was assessed using Short Form-12 version 2 (SF-12v2), disease activity was investigated using eight Performance Scales (PS) and three Functionality Sca

SUBMITTER: Briggs FB 

PROVIDER: S-EPMC5494015 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature